Physician

Thomas M Math, MD

According to 2025 Medicare claims, Thomas Math, MD (NPI: 1215927835) practices infectious disease in the St. Cloud, MN market, with the plurality of this provider's patient population coming from Stearns, MN. This provider's primary affiliated billing organization is CENTRACARE CLINIC (NPI: 1043212665; TIN: 411806657) and primary practice location at 56303-1901. Math is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), Caravan Collaborative Pathways (ACO ID: A4604), Aledade 103 Upper Midwest MSSP (ACO ID: A5003), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Math's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 546 traditional Medicare patients, billed 1,415 HCPCS/CPT codes, and received $126,605 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,922 prescription claims across 395 beneficiaries totaling $1,588,981 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). DME data shows 87 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $91,307 to $126,605. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $611,188 to $1,588,981. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$69K$138K2015 Medicare payment: $91,307 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $79,404 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $82,135 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $93,490 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $138,035 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $115,347 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $129,934 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $137,140 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $119,432 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $126,605 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154761,457$91,307
20164411,291$79,404
20173761,111$82,135
20184181,329$93,490
20196191,703$138,035
20205571,366$115,347
20215721,543$129,934
20225291,616$137,140
20235211,394$119,432
20245461,415$126,605

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$863K$1.7M2015 Drug cost: $611,188 (USD; Tot_Drug_Cst)2016 Drug cost: $894,132 (USD; Tot_Drug_Cst)2017 Drug cost: $1,054,818 (USD; Tot_Drug_Cst)2018 Drug cost: $1,313,709 (USD; Tot_Drug_Cst)2019 Drug cost: $1,403,071 (USD; Tot_Drug_Cst)2020 Drug cost: $1,559,514 (USD; Tot_Drug_Cst)2021 Drug cost: $1,670,009 (USD; Tot_Drug_Cst)2022 Drug cost: $1,725,273 (USD; Tot_Drug_Cst)2023 Drug cost: $1,588,329 (USD; Tot_Drug_Cst)2024 Drug cost: $1,588,981 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151971,246$611,188
20162531,641$894,132
20172821,818$1,054,818
20183302,037$1,313,709
20193391,948$1,403,071
20203832,247$1,559,514
20213691,992$1,670,009
20223241,924$1,725,273
20233451,985$1,588,329
20243951,922$1,588,981

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$78K$157K2021 Medicare payment: $59,047 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $124,560 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $74,393 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $156,910 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R13$59,047
2022N/R91$124,560
2023N/R68$74,393
2024N/R87$156,910

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes298344$126
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes161183$92
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more80123$91
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes136243$87
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes215405$58

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BiktarvyBictegrav/Emtricit/Tenofov Ala1524,740$632,893
GenvoyaElviteg/Cob/Emtri/Tenof Alafen511,950$249,796
OdefseyEmtricitab/Rilpiviri/Tenof Ala24720$85,818
DescovyEmtricitabine/Tenofov Alafenam391,170$84,711
TivicayDolutegravir Sodium361,080$78,959

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mgNN/R13$61,458
J1559Injection, immune globulin (hizentra), 100 mgNN/R15$48,887
J1557Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mgNN/R13$39,837
Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)NN/R16$5,274
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R15$1,281

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Thomas M. Math, MD?

Tedicare shows public-source Medicare data for Thomas M. Math, MD (NPI 1215927835), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas M. Math, MD have ACO affiliation data?

Thomas M. Math, MD is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Aledade 103 Upper Midwest MSSP (MSSP, ACO ID A5003), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Thomas M. Math, MD?

Thomas M. Math, MD is linked to CENTRACARE CLINIC (billing NPI 1043212665) in the available physician profile data.

Does Thomas M. Math, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.